FrancophonIA/ELRC3.0 huggingface dataset:
English: Posaconazole SP can be used to prevent invasive fungal infections in patients whose immune system is weakened.
Estonian: Posaconazole SP-d võib kasutada nõrgenenud immuunsüsteemiga patsientidel invasiivsete seeninfektsioonide ennetamiseks.
English: What is Posaconazole SP?
Estonian: Mis on Posaconazole SP?
English: Posaconazole SP is an antifungal medicine.
Estonian: Posaconazole SP on seenevastane ravim.
English: The medicine was more effective than fluconazole or itraconazole in cancer patients, with 2% of patients developing an infection in the Posaconazole SP group, and 8% in the comparator group.
Estonian: Vähihaigete ravimisel oli Posaconazole SP efektiivsem kui flukonasool või itrakonasool, nimelt tekkis Posaconazole SP-ga ravitud rühmas infektsioon 2%-l, kuid võrdlusravimiga ravitud rühmas 8%-l patsientidest.
English: What is the risk associated with Posaconazole SP?
Estonian: Millised on Posaconazole SP-ga kaasnevad riskid?
English: In invasive aspergillosis, a successful response at the end of treatment was seen in 42% of the patients taking Posaconazole SP, compared with 26% of the comparison group.
Estonian: Invasiivset aspergilloosi põdevatel patsientidel tekkis Posaconazole SP kasutamisel soovitud ravivastus ravi lõpuks 42%-l, kuid võrdlusrühmas 26%-l patsientidest.
English: The list of fungi against which Posaconazole SP is active can be found in the Summary of Product Characteristics (also part of the EPAR).
Estonian: Posaconazole SP suhtes tundlike seente loetelu on esitatud ravimi omaduste kokkuvõttes (samuti Euroopa avaliku hindamisaruande osa).
English: How does Posaconazole SP work?
Estonian: Kuidas Posaconazole SP toimib?
English: How has Posaconazole SP been studied?
Estonian: Kuidas Posaconazole SP-d uuriti?
English: The full EPAR for Posaconazole SP is available here.
Estonian: Posaconazole SP Euroopa avaliku hindamisaruande täisteksti leiate siit.
English: What benefit has Posaconazole SP shown during the studies?
Estonian: Milles seisneb uuringute põhjal Posaconazole SP kasulikkus?
English: • Cisapride (used for stomach problems),
Estonian: • tsisapriid (kasutatakse maoprobleemide korral),
English: Page 2/2©EMEA 2007
Estonian: Lk 2/2©EMEA 2007
English: The marketing authorisation was renewed on 25 September 2007.
Estonian: Müügiluba pikendati 25. septembril 2007.
English: Immunity against infection is usually established after around three days and lasts for up to a year.
Estonian: Immuunsus nakkuse vastu tekib tavaliselt ligikaudu kolme päeva pärast ja kestab kuni üks aasta.
English: This makes it suitable for use in a vaccine.
Estonian: Seepärast on seda sobiv vaktsiinina kasutada.
English: The vaccine may be administered by veterinarians only.
Estonian: Vaktsiini võib manustada ainult veterinaararst.
English: Occasional side effects include sneezing, coughing and a mild and temporary discharge from the eyes or nose.
Estonian: Vahetevahel esinevad kõrvalnähud on aevastamine, köhimine ja vähene mööduv eritis silmadest või ninast.
English: In animals that show more severe signs, treatment with an antibiotic may be necessary.
Estonian: Raskemate nähtudega loomade puhul võib osutuda vajalikuks antibiootikumravi.
English: When a cat is given the vaccine, the immune system recognises the bacteria as ‘foreign' and makes a special type of antibodies against them.
Estonian: Kui kassile antakse vaktsiini, peab immuunsüsteem baktereid „võõrasteks“ ja produtseerib nende vastu erilist tüüpi antikehi.
English: In case of accidental administration to people seek medical advice immediately and show the Package Leaflet or label to the doctor.
Estonian: Juhusliku manustamise korral pöörduda kohe arsti poole ja näidata ravimi pakendi infolehte või etiketti.
English: The effectiveness of Nobivac Bb was investigated in three main studies involving cats of various breeds.
Estonian: Nobivac Bb efektiivsust uuriti kolmes põhiuuringus, millesse kaasati eri tõugu kasse.
English: Nobivac Bb is a vaccine.
Estonian: Nobivac Bb on vaktsiin.
English: Cats are vaccinated by giving a 0.2-ml dose into one nostril.
Estonian: Kasside vaktsineerimiseks manustatakse neile ühte ninasõõrmesse 0,2 ml annus.
English: Although the risk for people with weak immune systems becoming infected with B. bronchiseptica is extremely low, it is advised that cats which are in close contact with such people are not vaccinated with Nobivac Bb, since they can shed the bacteria intermittently for up to a year after vaccination.
Estonian: Kuigi nõrga immuunsüsteemiga inimestel on oht nakatuda B. bronchiseptica'ga äärmiselt väike, ei ole nende inimestega lähedalt kokkupuutuvaid kasse soovitatav Nobivac Bb-ga vaktsineerida, sest kuni ühe aasta jooksul alates vaktsineerimisest võib kassidelt aeg-ajalt erituda baktereid.
English: The live bacterium strain included in Nobivac Bb differs from other types of B. bronchiseptica because it is missing certain molecules and is therefore less likely to cause disease.
Estonian: Nobivac Bb-s sisalduv elusbakteri tüvi erineb muud tüüpi B. bronchiseptica'test selle poolest, et selles puuduvad teatud molekulid ning seetõttu on haiguse põhjustamine vähem tõenäoline.
English: The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Nobivac Bb exceed the risks of its use.
Estonian: Veterinaarravimite komitee otsustas, et Nobivac Bb kasutamisel on kasulikkus suurem kui sellega seotud ohud.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Nobivac Bb to Intervet International B.V. on 10 September 2002.
Estonian: Euroopa Komisjon väljastas Nobivac Bb müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, ettevõttele Intervet International B.V.
English: The main studies showed that Nobivac Bb was effective in reducing the symptoms caused by B. bronchiseptica.
Estonian: Põhiuuringud näitasid Nobivac Bb efektiivsust B. bronchiseptica põhjustatud sümptomite vähendamisel.
English: In the future, the immune system will be able to produce these antibodies more quickly when it is again exposed to the bacteria.
Estonian: Kui siis immuunsüsteem uuesti nende bakteritega kokku puutub, on ta võimeline antikehi kiiremini produtseerima.
English: Nobivac Bb is a dry substance and solvent that are made up into a suspension, which is given via the nose.
Estonian: Nobivac Bb on pulber ja lahusti, millest valmistatavat suspensiooni manustatakse nina kaudu.
English: This summary was last updated on 25 September 2007.
Estonian: Kokkuvõtte viimane uuendus: 25-09-2007.
English: Other information about Nobivac Bb:
Estonian: Muu teave Nobivac Bb kohta
English: Vaccines against B. bronchiseptica that are administered through the nose are also used in dogs.
Estonian: B. bronchiseptica vastaseid ninakaudseid vaktsiine kasutatakse ka koertel.
English: Nobivac Bb was the first live B. bronchiseptica vaccine licensed for use in cats.
Estonian: Nobivac Bb oli esimene B. bronchiseptica vaktsiin, millele anti kassidel kasutamiseks müügiluba.
English: Nobivac Bb is a vaccine that contains a live bacterium Bordetella bronchiseptica strain B-C2.
Estonian: Nobivac Bb on vaktsiin, mis sisaldab elusbakteri Bordetella bronchiseptica tüve B-C2.
English: What is the risk associated with Nobivac Bb?
Estonian: Millised on Nobivac Bb-ga kaasnevad riskid?
English: Why has Nobivac Bb been approved?
Estonian: Miks Nobivac Bb heaks kiideti?
English: Nobivac Bb is used to vaccinate cats aged one month or older against the disease (a flu-like illness) caused by the bacterium B. bronchiseptica.
Estonian: Nobivac Bb-d kasutatakse ühekuuliste või vanemate kasside vaktsineerimiseks bakteri B. bronchiseptica põhjustatud (gripilaadse) haiguse vastu.
English: Nobivac Bb contains a type of live B. bronchiseptica called strain B-C2.
Estonian: Nobivac Bb sisaldab elusat B. bronchiseptica tüve B-C2.
English: What is Nobivac Bb?
Estonian: Mis on Nobivac Bb?
English: How does Nobivac Bb work?
Estonian: Kuidas Nobivac Bb toimib?
English: The cats were vaccinated with Nobivac Bb before being challenged by being exposed to wild-type B. bronchiseptica.
Estonian: Kasse vaktsineeriti Nobivac Bb-ga ja viidi siis kontakti loodusliku B. bronchiseptica'ga.
English: How has Nobivac Bb been studied?
Estonian: Kuidas Nobivac Bb efektiivsust uuriti?
English: What benefit has Nobivac Bb shown during the studies?
Estonian: Milles seisneb uuringute põhjal Nobivac Bb kasulikkus?
English: What is Nobivac Bb used for?
Estonian: Milleks Nobivac Bb-d kasutatakse?
English: Gonazon implants were authorised by an extension application, granted by the European Commission in January 2007.
Estonian: Gonazoni implantaadid kiideti heaks laiendamise taotlusega, mille Euroopa Komisjon rahuldas 2007. aasta jaanuaris.
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Gonazon to Intervet International BV on 22 July 2003.
Estonian: Euroopa Komisjon väljastas Gonazoni müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, ettevõttele Intervet International BV 22. juulil 2003.
English: The recommended dose is 32 μg/kg bodyweight.
Estonian: Soovitatav annus on 32 μg kehamassi kg kohta.
English: In most cases, an effect was induced within 6-11 days of treatment, and ovulation was generally advanced by 2-3 weeks.
Estonian: Enamikel juhtudel piisas saadi toime 6-11 ravipäevaga ning ovulatsioon tekkis tavaliselt 2-3 nädalat kiiremini.
English: What is Gonazon?
Estonian: Mis on Gonazon?
English: The main measure of effectiveness was the speed of response to treatment and the advance in time and synchronisation of the spawning period.
Estonian: Peamine tõhususe näitaja oli ravile reageerimise kiirus ning kudemisperioodi saavutamise ja sünkroniseerimise kiirus.
English: This optimises organisation of the fish farm.
Estonian: See on kasulik kalakasvanduse töökorralduse optimeerimiseks.
English: Other information about Gonazon:
Estonian: Muu teave Gonazoni kohta
English: The implant may be administered to bitches from the age of four months (blocking reproductive function for an average of 12 months) to 6 years (blocking reproductive function for an average of 11 months).
Estonian: Implantaati võib emastele koertele manustada alates neljandast elukuust (pärsib paljunemisfunktsiooni keskmiselt 12 kuuks) kuni 6. eluaastani (pärsib paljunemisfunktsiooni keskmiselt 11 kuuks).
English: In some cases this can be caused by use of Gonazon too early in the spawning season.
Estonian: Mõnel juhul võib selle põhjuseks olla Gonazoni kasutamine liiga varases kudemishooaja järgus.
English: Why has Gonazon been approved?
Estonian: Miks Gonazon heaks kiideti?
English: What is the risk associated with Gonazon?
Estonian: Millised on Gonazoniga kaasnevad riskid?
English: Data on the return to oestrus, ovulatory oestrus and subsequent fertility once treatment has ended (i.e. once the implant had been removed) were limited, especially for repeated treatment.
Estonian: Andmed indluse ja ovulatsiooni taastekke ja edasise viljakuse kohta ravi järel (pärast implantaadi eemaldamist) on piiratud, eriti ravimi korduval kasutamisel.
English: This summary was last updated in December 2006.
Estonian: Kokkuvõtte viimane uuendus: 12-2006.
English: The CVMP recommended that Gonazon should be given a marketing authorisation.
Estonian: Veterinaarravimite komitee soovitas seepärast anda Gonazonile müügiluba.
English: Gonazon implant is rectangular in shape, off white, with dimensions of 14x3x1 mm.
Estonian: Gonazoni implantaat on valkjas ja nelinurkne, mõõtmetega 14 × 3 × 1 mm.
English: The package leaflet or the label should be shown to the doctor.
Estonian: Arstile tuleb näidata pakendi infolehte või ravimi etiketti.
English: Operators should wash their hands after use of the product.
Estonian: Pärast ravimi käsitsemist tuleb pesta käsi.
English: If the concentrated solution or the diluted solution is spilled onto the skin or into the eyes, or the implant is accidentally self-injected, medical advice should be sought immediately.
Estonian: Kui kontsentreeritud või lahjendatud lahus satub nahale või silma või süstite endale juhuslikult implantaadi, tuleb viivitamata pöörduda arsti poole.
English: Good efficacy has been demonstrated for the prevention of heat and ovulation in adult bitches aged up to 7 years during the one or two years of treatment.
Estonian: Ravimiga on näidatud head efektiivsust inna ja ovulatsiooni vältimisel kuni 7-aastatel täiskasvanud emastel koertel ühe- või kaheaastase ravi jooksul.
English: Gonazon contains azagly-nafarelin, which is an analogue of a natural hormone called gonadotrophinreleasing hormone (GnRH).
Estonian: Gonazon sisaldab asaglünafareliini, mis on kehaomase hormooni gonadoliberiini (GnRH) analoog.
English: How does Gonazon work?
Estonian: Kuidas Gonazon toimib?
English: In bitches, the results of two field studies with Gonazon implants were provided, one investigating a single administration, another one the repeated application over a second year.
Estonian: Emaste koerte kohta esitati kaks Gonazoni implantaatidega läbi viidud uuringut, milles ühes käsitleti ühekordset manustamist ja teises korduvat manustamist ka järgmisel aastal.
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR)
Estonian: European Medicines Agency Veterinary Medicines
English: Bitches treated with Gonazon generally failed to display heat during the study compared to bitches who did not receive the treatment.
Estonian: Gonazoni saanud emastel koertel uuringu aja jooksul üldiselt inda ei tekkinud, võrreldes nende emaste koertega, kes ravi ei saanud.
English: Gonazon is authorised as a concentrate that is made into a solution for injection for salmonid fish and also as an implant for dogs.
Estonian: Gonazon on heaks kiidetud kontsentraadina, millest lõhilastele manustamiseks valmistatakse süstelahus, ja koertele ettenähtud implantaadina.
English: Operators should wear gloves when mixing the concentrate solution or handling the implant and avoid self injection.
Estonian: Lahuse valmistamisel kontsentraadist või implantaadi käsitsemisel peab kandma kindaid ja vältima enese süstimist.
English: In dogs, administration of higher doses of GnRH agonists over a period of time desensitises the pituitary gland with the result that release of gonadotrophins is suppressed, leading to a suppression of reproductive function.
Estonian: Koertel vähendab GnRH agonistide suurte annuste manustamine teatud aja jooksul hüpofüüsi tundlikkust, mille tulemusena pärsitakse gonadotropiinide vabanemist, mis omakorda pärsib reproduktiivfunktsiooni.
English: In case of accidental contact with either the skin or the eyes, rinse thoroughly with water.
Estonian: Kui ravim satub juhuslikult nahale või silma, loputage nahka ja silmi rohke veega.
English: If you want more information on the basis of the CVMP recommendations, read the Scientific Discussion
Estonian: Kui soovite lisateavet veterinaarravimite komitee soovituste aluse kohta, lugege palun teadusliku arutelu kokkuvõtet (samuti Euroopa avaliku hindamisaruande osa).
English: GnRH controls reproduction in fish by increasing the secretion of the gonadotrophins controlling egg production.
Estonian: GnRH reguleerib kalade reproduktsiooni, suurendades marjaheidet reguleerivate gonadotropiinide eritumist.
English: What is Gonazon used for?
Estonian: Milleks Gonazoni kasutatakse?
English: The Committee for Medicinal Products for Veterinary Use (CVMP) agreed that the benefits of Gonazon are greater than any risks for the induction and synchronisation of ovulation for the production of eyed-eggs and fry.
Estonian: Veterinaarravimite komitee otsustas, et Gonazoni kasulikkus selle kasutamisel marjaheitmise esilekutsumiseks ja sünkroniseerimiseks silmtäpiga loodete ja vastsete saamiseks on suurem kui sellega kaasnevad ohud.
English: Information on the prescription status of this product may be found on the labelling.
Estonian: Teave selle kohta, kas toode on retseptiravim, on esitatud karbi etiketil.
English: Gonazon implants are effective in prevention of gonadal function via long term blockade of gonadotrophin synthesis.
Estonian: Gonazoni implantaadid pärsivad tõhusalt sugunäärmete talitust, blokeerides pikaajaliselt gonadotropiinide sünteesi.
English: In fish, Gonazon has been studied in three studies of rainbow trout, two studies of Altlantic salmon, and one study of Arctic charr.
Estonian: Kaladel uuriti Gonazoni kolmes teraspea-lõhel, kahes lõhel ja ühes arktika paalial tehtud uuringus.
English: In fish, the results of the trials showed that Gonazon was effective to induce and synchronise ovulation.
Estonian: Uuringutulemused näitasid, et kaladel oli Gonazon marjaheitmise esilekutsujana ja sünkroniseerijana tõhus.
English: What benefit has Gonazon shown during the studies?
Estonian: Milles seisnes uuringute põhjal Gonazoni kasulikkus?
English: In bitches, it has been demonstrated that the insertion of a Gonazon implant will prevent heat and ovulation in adult bitches aged up to 7 years during the one or two years of treatment.
Estonian: Emastel koertel on näidatud, et Gonazoni implantaadi kasutamine väldib ühe- kuni kaheaastase ravi vältel kuni 7-aastatel täiskasvanud emastel koertel inda ja ovulatsiooni.
English: Following anaesthesia, the fish are injected intraperitoneally (into the area that contains the abdominal organs) along the central line, 1/2 to 1 fin length in front of the pelvic fin base.
Estonian: Kaladele tehakse anesteesias süst piki keskjoont ½ kuni 1 uime pikkuse jagu kõhuuime algusest ettepoole kõhuõõnde.
English: In fish, the injection of Gonazon may be associated with a reduction in fecundity (ability to breed), egg quality and survival to the eyed-egg stage.
Estonian: Kaladel võib Gonazoni süstimisega kaasneda sigivuse ja marja kvaliteedi langus ning järglaste suurem suremus silmtäpiga loote staadiumis.
English: Gonazon is injected subcutaneously, in the region of the umbilicus.
Estonian: Gonazon manustatakse subkutaanse (nahakaudse) süstena naba piirkonda.
English: In bitches, Gonazon works by inhibition of the production of sex steroids and may be associated with rare cases of vaginitis in prepubertal females.
Estonian: Emastel koertel pärsib Gonazon suguhormoonide tootmist ning see võib puberteedieelsetel emastel koertel olla seotud harvaesineva tupepõletikuga.
English: The use of Gonazon while not necessarily improving reproductive performance over the course of the spawning season, by synchronising spawning will shorten the time span dedicated to eyed egg production.
Estonian: Kuigi Gonazoni kasutamine kudemishooajal ei pruugi paljunemist lisada, kiirendab see kudemise sünkroniseerimise kaudu marja arenemist silmtäpiga loodeteks.
English: In fish, Gonazon is used to induce and synchronise ovulation (egg production) in female salmonids such as Atlantic salmon, rainbow trout, brown trout and Arctic charr for the production of eyed-eggs and fry.
Estonian: Emastel lõhilastel, näiteks lõhel, teraspea-lõhel, meriforellil ja arktika paalial, kasutatakse Gonazoni ovulatsiooni (marjaheitmise) esilekutsumiseks ja sünkroniseerimiseks silmtäpiga loodete ja vastsete saamiseks.
English: How has Gonazon been studied?
Estonian: Kuidas Gonazoni efektiivsust uuriti?
English: Gonazon contains the active substance azagly-nafarelin.
Estonian: Gonazon sisaldab toimeainena asaglünafareliini.
English: In bitches, Gonazon is also indicated for the prevention of gonadal function via long term blockade of gonadotrophin synthesis.
Estonian: Emastel koertel on Gonazon näidustatud sugunäärmete funktsiooni pärssimiseks, blokeerides pikaajaliselt gonadotropiinide (suguhormoonide eraldumist reguleerivate hormoonide) sünteesi.
English: This reference product was approved through the centralised procedure and has been marketed in Europe since November 1995.
Estonian: Nimetatud ravim on müügiloa saanud tsentraliseeritud menetluse kaudu ja seda turustatakse Euroopas alates 1995. aasta novembrist.
English: Grounds for positive opinion
Estonian: Positiivse otsuse põhjendused
English: Scientific conclusions and grounds for positive opinion presented by the European Medicines Agency
Estonian: Euroopa Ravimiameti esitatud teaduslikud järeldused ning positiivse arvamuse alused
English: The necessity of human data was also discussed - focussing on at least the first 3 hours, since in vitro data does not predict the rate of release in human blood.
Estonian: Inimravimite komitee arutas ka vajadust inimuuringute andmete järele, mis hõlmaksid vähemalt esimest kolme infusioonijärgset tundi, sest in vitro andmed ei võimalda ennustada ravimi vabanemise kiirust inimese veres.
English: Overall summary of the scientific evaluation of Docetaxel Teva Generics (see Annex I)
Estonian: Docetaxel Teva Genrics ja sarnaste nimetuste (vt I lisa) teadusliku hindamise üldkokkuvõte
English: The applicant was invited to attend an oral explanation before the CHMP on the 15 February 2011 to defend their position with respect to their arguments presented in their responses.
Estonian: Müügiloa taotlejale pakuti võimalust osaleda suulisel arutelul enne inimravimite komitee 15. veebruari 2011. aasta istungit, et kaitsta oma vastuses esitatud argumente.
English: Following infusion, the active ingredient and excipients are highly diluted in the patient's plasma.
Estonian: Infusiooni järel lahjenevad nii toimeaine kui ka abiained olulisel määral patsiendi vereplasmas.
English: The data presented by the applicant was not considered to be sufficient to claim similarity, and as this is a new complex formulation clinical data was considered to be necessary.
Estonian: Müügiloa taotleja esitatud andmeid ei saa pidada piisavaks, et kinnitada ravimite sarnasust, mistõttu uue keerulise ravimvormi korral on vaja ka kliinilisi andmeid.
English: In the second round of this Referral, it was made clear that it is very unlikely that polysorbate 80 micelles remain present for 3 hours after infusion of Taxotere, with possible effect on Docetaxel pharmacokinetics.
Estonian: Käesoleva esildise teistkordsel käsitlemisel jõuti järeldusele, et on äärmiselt ebatõenäoline polüsorbaat 80 mitsellide püsimine veres veel 3 tundi pärast Taxotere infusiooni, millel võiks olla mõju dostetakseeli farmakokineetikale.
English: The lack of safety issues caused by these excipients was also supported by animal data.
Estonian: Ohutusprobleemide puudumist nende abiainete kasutamisel kinnitavad ka loomadel tehtud uuringute tulemused.
English: Since the pharmaceutical form of the Docetaxel Teva Generics (powder for solution for infusion) differs from the reference product (concentrate for solution for infusion) a hybrid application marketing authorisation application (MAA) for Docetaxel Teva Generics 20 mg / 80 mg, Powder and Solvent for Solution for Infusion, 20 mg and 80 mg was submitted, in accordance with Directive 2001/83/EC, article 10(3).
Estonian: Et Docetaxel Teva Genericsi ravimvorm (pulber infusioonilahuse valmistamiseks) erineb võrdlusravimi ravimvormist (kontsentraat infusioonilahuse valmistamiseks), esitati Docetaxel Teva Generics 20 mg/80 mg, 20 mg ja 80 mg infusioonilahuse pulbri ning lahusti müügiloa taotlemiseks hübriidtaotlus direktiivi 2001/83/EÜ artikli 10 lõike 3 alusel.
English: The Applicant discussed these issues in their responses to the Referral List of Outstanding Issues (LoOI), as discussed below:
Estonian: Müügiloa taotleja käsitles neid küsimusi oma vastustes esildises lahendamata küsimustele, mis on kokku võetud allpool.
English: Moreover, polysorbate 80 micelles are very unstable and will disappear rapidly due to hydrolyses and metabolism by plasma carboxyesterases.
Estonian: Mis veelgi tähtsam, polüsorbaat 80 mitsellid on väga ebastabiilsed ja kaovad verest kiiresti hüdrolüüsi ja metaboliseerumise tõttu vereplasma karboksüesteraaside poolt.
English: The excipients povidone K-12 and HP-b-CD that are used in Docetaxel Teva Generics, but are not used in Taxotere, are known from other medicinal products, and no safety issues are expected.
Estonian: Abiained povidoon K12 ja HP-b-CD, mida kasutatakse Docetaxel Teva Genericsis, aga ei kasutata Taxoteres, on hästituntud abiained teistes ravimites, mistõttu nendega seoses ei ole oodata ohutusprobleeme.